Management of Insomnia in the Elderly
Cognitive behavioral therapy for insomnia (CBT-I) should be the first-line treatment for elderly patients with chronic insomnia due to its proven efficacy, long-lasting effects, and minimal side effects compared to pharmacological options. 1
Initial Assessment
- Determine if insomnia is primary or comorbid with other conditions, as older adults often have multiple contributing factors 1
- Evaluate prescription and non-prescription medications that may cause or exacerbate insomnia (β-blockers, bronchodilators, corticosteroids, decongestants, diuretics, SSRIs, SNRIs) 1
- Assess for common behaviors that impair sleep: daytime napping, excessive time in bed, insufficient activity, evening alcohol consumption, and late heavy meals 1
Non-Pharmacological Interventions (First-Line)
Cognitive Behavioral Therapy for Insomnia (CBT-I)
- Combines multiple behavioral treatments with cognitive restructuring 1
- Demonstrated effectiveness with effects sustained for up to 2 years in older adults 1
- Most effective non-pharmacological approach with strong evidence base 1
Sleep Restriction/Compression Therapy
- Limit time in bed to match actual sleep time based on sleep logs 1
- Gradually increase time in bed by 15-20 minute increments as sleep efficiency improves 1
- Sleep compression (gradual reduction) may be better tolerated by elderly patients than immediate restriction 1
Stimulus Control
- Strengthen association between bedroom and sleep 1
- Key instructions include:
Sleep Hygiene Education
- Most effective when combined with other modalities rather than as standalone treatment 1
- Address environmental factors: comfortable bedroom temperature, noise reduction, light control 1
- Avoid sleep-fragmenting substances (caffeine, nicotine, alcohol) 1
- Develop a relaxing pre-sleep ritual 1
Relaxation Techniques
- Progressive muscle relaxation, guided imagery, diaphragmatic breathing 1
- Help achieve calm state conducive to sleep onset 1
Pharmacological Interventions (Second-Line)
Pharmacotherapy should only be considered when CBT-I alone has been unsuccessful, using a shared decision-making approach that discusses benefits, harms, and costs of short-term medication use. 1
FDA-Approved Medications for Insomnia
- Start all medications at the lowest available dose in elderly patients 1
Non-Benzodiazepines (Z-drugs)
- Eszopiclone: Effective for sleep maintenance in elderly; improved sleep quality, reduced wake time after sleep onset 2
- Zolpidem: Reduces sleep latency in elderly; use lowest effective dose (5mg) 3
- Consider potential adverse effects: next-day impairment, confusion, memory issues 2, 3
Melatonin Receptor Agonist
- Ramelteon: Reduces latency to persistent sleep in elderly with chronic insomnia 4
- Lower abuse potential compared to other sleep medications 4
Orexin Receptor Antagonists
- Suvorexant: Newer medication showing improvement in sleep maintenance with minimal side effects 5, 6
Low-dose Doxepin
- Effective for sleep maintenance insomnia in elderly patients 6
Medication Selection Based on Symptoms
- Sleep onset insomnia: Ramelteon or short-acting Z-drugs 6
- Sleep maintenance: Suvorexant or low-dose doxepin 6
- Both onset and maintenance: Eszopiclone or extended-release zolpidem 6
Common Pitfalls and Caveats
- Avoid benzodiazepines when possible due to higher risk of adverse effects in elderly (falls, cognitive impairment, dependence) 1, 6
- Sleep hygiene education alone is usually insufficient for treating chronic insomnia 1
- Pharmacological treatments should be limited to short-term use when possible 1
- Medication side effects may be more pronounced in elderly due to reduced clearance and increased sensitivity 1
- Regular reassessment is necessary to evaluate treatment effectiveness and potential adverse effects 1